1Garnacho-Montero J, Garcia-Garmendia JL,Barrero-Almodovar, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med, 2003,31(12): 2742-2751
1Sheen- Chen S, Chen W, Eng H, et al. Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control, 2000, 28(4) :298.
2Westphal JF, Brogard JM. Biliary tract infections: a guide to drug treatment. Drugs, 1999,57(1): 81.
3Nikado H. Outer mernberance barrier as a mechanism of antimicrobial resistance [ J ]. Antimicrob Agents Chemother,1989,33(11) : 1831.
4Takiff HT, Cimino M, musso MC, et al. Efflux pump of the proton antiporter family confers low- level fluroquinolone resistance in Mycobacterium srnegmatis , [ J ]. Proc Natl Acad Sci USA, 1996,93 : 362.
5Gull MJ, Brenwald NP, Wise R. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae [ J ]. Antimicrob Ageqtts Chemother, 1999,43 : 187.
6Cecchetti V, Fravolini A, Palumbo M, et al. Potent 6 - de -sfluoro- 8 - methylquinolone as new lead compound in antibacterial chemotherapy [ J ]. J Med Chem, 1996,39 (25) :4952.
7Renau TE, Leger R. Flamme EM, et al. Inhibitors of efflux pumps in Pseudornonas aeuruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin [ C]. Abstracts 39th ICAAC, 1999:326.
8Markham PN. Inhibition of the emergence of ciproflixacin resistance in Streptococcus" preumoniae by the multidrug efflux inhibitor reserpine [J ]. Antimicrob Agents Chemther, 1999, 43:988.
9Aeschlimann JR, Dresser LD, kaatz G W, et al. Effects of NorA inhibitors on in vitro antibacterial activities and pastantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus [ J ].Antimicrob Agents Chemother , 1999,43 : 335.
10Markham PN, Neyfakh AA. Inhibition of the multidrug transporter Nora prevents emergerce of norflox aein resistance in Staphylococcus aureus [J ]. Antimicrob Agents Chemother ,1996,40 : 2673.
7Farrell DJ, Morrissey I, Bakker S, et al. Global distribution of TEM-1 and ROB 1 beta-lactamases in Haemophilus influenzae [J]. J Antimicrob Chemother, 2005,56 (4) 773-776.
8Marco F, Garcia-de Lomas J, Garcia-Rey C, et al. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998 -1999 [J]. Antimicrob Agents Chemother, 2001, 45(1l) :3226- 3228.
9Poirel L, Nordmann P. Carbapenem resistance in Acineto- batter baumannii: mechanisms and epidemiology[J]. Clin Microbiol Infect Dis,2006,12(9)826-836.
10Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baurnannii[J]. Nat Rev Microbiol,2007,5(12) :939-951.
